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Abstract
Chamaemelum nobile (Asteraceae) commonly known as ʹ Roman chamomileʹ is a medicinal 
plant used for numerous diseases in traditional medicine, although its anticancer activity is 
unknown. The present study was carried out to investigate the anticancer as well as apoptotic 
activity of ethyl acetate fraction of C. nobile on different cancerous cell lines. The cells were 
treated with varying concentrations (0.001- 0.25 mg/mL) of this fraction for 24, 48 and 72 h. 
Apoptosis induced in MCF-7 cells following treatment with ethyl acetate fraction was measured 
using annexin V/PI, flowcytometry and western blotting analysis. The results showed that C. 
nobile ethyl acetate fraction revealed relatively high antiproliferative activity on MCF-7 cells; 
however, it caused minimal growth inhibitory response in normal cells. The involvement of 
apoptosis as a major cause of the fraction-induced cell death was confirmed by annexin-V/
PI assay. In addition, ethyl acetate fraction triggered the mitochondrial apoptotic pathway 
by decreasing the Bcl-2 as well as increasing of Bax protein expressions and subsequently 
increasing Bax/Bcl-2 ratio. Furthermore, decreased proliferation of MCF-7 cells in the presence 
of the fraction was associated with G2/M phase cell cycle arrest. These findings confirm that 
ethyl acetate fraction of C.nobile may contain a diversity of phytochemicals which suppress the 
proliferation of MCF-7 cells by inducing apoptosis. 
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Introduction
Cancer is a major cause of death worldwide in 
which deregulated proliferation of abnormal cells 
leads to disruption of surrounding tissues (1). 
Based on the report of The International Agency 
for Research on Cancer (IARC), the specialized 
cancer agency of the World Health Organization, 
about 14.9 million cancer cases were identified 
around the world in 2013, of these 7.7 million 
cases were in men and 6.9 million in women and 
further this number is expected to increase to 
24 million by 2035 (2). Among different types 
of cancer, breast cancer is a common malignant 
tumor in women. Since there are noticeable 
failures in clinical therapy including radiation, 
chemotherapy, immunomodulation and surgery 
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in treatment of cancer, a need of alternative 
strategies in cancer treatment always exists (3). 
In this regard, many anticancer agents have 
been developed and several of them are from 
natural origin (4). 
Medicinal plants have long been used in 
treatment of different types of diseases due 
to less toxicity compared with the modern 
chemotherapy (5).  According to the estimation 
of the World Health Organization (WHO), 
almost 65% of the world’s inhabitants trust on 
traditional medicine for their primary health 
care (6). This is because medicinal plants 
contain secondary metabolites which could 
treat various diseases including cancer with 
less toxic effects (7).
Chamomile as a well-documented 
medicinal plant in the world was widely used 
for different diseases. Its usage dates back 
to ancient Egyptians to relieve fever and sun 
stroke.  In the sixth century, it was used for 
treatment of insomnia, back pain, neuralgia, 
rheumatism, skin conditions, indigestion, 
flatulence, headaches, and gout (8). There are 
different types of chamomile, among them, 
Roman chamomile (Chamaemelum nobile) 
and German chamomile (Matricaria recutita) 
from the Asteraceae family are most popular 
(9, 10). Roman chamomile has been used for 
centuries as anti-inflammatory, antioxidant, 
antibacterial and healing medicine (11). 
Different types of bioactive compounds are 
present in chamomile, including phenolic 
compounds (12, 13). Phenolic compounds, 
mainly flavonoids, proved to have potency to 
regulate proliferation and cell death pathways 
leading to cancer (14) via various mechanisms 
including cell growth inhibition and apoptosis 
induction (15). 
To our best knowledge, reports are not 
available on the antiproliferative activity of 
Chamaemelum nobile (L.) on cancer cells. 
Our primary screening study indicated that 
C. nobile ethyl acetate fraction had enough 
potency to inhibit cancer cells growth. 
Considering these data and knowing that 
ethyl acetate fraction may contain phenolic 
compounds with antiproliferative activity, we 
decided to explore the anticancer effects as 
well as apopotic mechanism induced by the 
ethyl acetate fraction obtained from C. nobile 
leaves against three cancer cell lines: MCF-
7 (human breast adenocarcinoma),  K562 
(human erythroleukemia)  and SKMEL-3 
(human malignant melanoma).
Experimental
Chemicals 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) and fetal bovine serum (FBS) were 
purchased from Gibco-BRL (Rockville, IN, 
USA). Anti-Bcl-2 (1:1000), anti-Bax (1:1000), 
anti- GAPDH (1:1000) and anti-rabbit IgG 
horseradish peroxidase (HRP) (1:10000) 
antibodies were purchased from Cell Signaling 
Technology (Beverly, MA, USA). All other 
chemicals were from Merck (Darmstadt, 
Germany) and Sigma-Aldrich (St Louis, MO, 
USA). ECL advance western blotting detection 
kit was prepared from General Electric Health 
Care Life Sciences (Buckinghamshire, UK).
Plant material and extracts preparation
C. nobile aerial parts were purchased from 
herbal medicine stores in Tehran, capital of 
Iran in 2012. It was characterized by herbarium 
department of Faculty of Pharmacy, Tehran 
University of Medical Sciences. 20 g of plant 
powder was extracted sequentially by solvents 
with different polarities including hexane, 
chloroform, ethyl acetate and methanol using a 
maceration method. The process was repeated 
3 times with the same plant material but using 
fresh solvents. After maceration, the extracts 
were filtered and evaporated to dryness on a 
rotary evaporator under reduced pressure below 
40 ºC. All the extracts were stored at 4 ºC until 
used for experiments. Yields were 2.66, 2.53, 
1.36 and 5.53% for hexane, chloroform, ethyl 
acetate and methanol fractions, respectively. 
Cell culture 
MCF-7 (human breast adenocarcinoma), 
K562 (human erythroleukemia) and SKMEL-3 
(human melanoma) cell lines were obtained 
from the National Cell Bank of Pasture Institute 
of Iran (NCBI). Cells were cultured in DMEM 
with 10% (v/v) FBS, (100 U⁄mL) penicillin and 
(100 µg ⁄mL) streptomycin under the conditions 
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of 5% CO2 at 37 ºC.
MTT cytotoxicity assay  
The effect of ethyl acetate fraction of 
Chamaemelum nobile on the cytotoxicity 
of MCF-7, K562 and SKMEL-3 cell lines 
was determined by MTT assay. The cell 
proliferation test is based on the ability of 
the mitochondrial succinate-tertrazolium 
reductase system to convert yellow tetrazolium 
salt, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 
diphenyltetrazolium bromide) to purple 
formazan dye. The cells were added to make 6-8 
× 103 cells/well in a 96-well plate including 200 
µL of complete culture medium and incubated 
for 24 h at 37 °C in 5% CO2. Afterwards, cells 
were exposed to different concentrations of 
ethyl acetate fraction (0.001- 0.25 mg/mL) and 
incubated for 24, 48 and 72 h. The solvent DMSO 
treated cells served as control. After incubation 
at 37 ºC in a humidified incubator, cells were 
treated with MTT (5 mg/mL) reagent for 4 h at 
37 ºC and then, the medium was removed by 
aspiration and 200 µL of DMSO was added per 
well. The absorbance at 545 nm was measured 
using ELISA Microplate Reader (Stat Fax-
2100, ST. Louis, USA) .The number of viable 
cells was proportional to the extent of formazan 
production. Cell viability was measured as 
the percentage of absorbance compared with 
control. The 50% inhibitory concentration (IC50) 
value, the concentration of extract required to 
inhibit 50% cell growth, was determined from 
concentration-response curves following a 24, 
48 and 72 h exposure times. All experiments 
were conducted with 3 replicates.
that the anticancer compounds extracted from C. nobile are concentrated in ethyl acetate 
fraction. 
 
Figure 1. Cytotoxic effects of ethyl acetate extract on a) MCF-7, b) SK-MEL-3 and c) K562 
cells after 24, 48 and 72 h treatment. Cells were treated with different concentrations of 
extract (0.001-0.25 mg/mL) .Values are presented as mean ± SE of three independent 
experiments. 
 
Table 1. IC50 values (mg of extract/mL) for antiproliferative activity of Chamaemelum nobile 
ethyl acetate extract towards MCF-7, K562 and SKMEL3 cells a. 
 
Cells Time Ethyl acetate fraction 
 24 h 0.09(0.07-0.1) 
MCF-7 48h 0.09(0.07-0.1) 
 72h  0.002(0.002-0.004) 
 24 h 0.06(0.05-0.07) 
K562 48h 0.04(0.03-0.04) 
 72h 0.04(0.03-0.04) 
 4  0.15 (0.14-0.17) 
Figure 1. Cytotoxic effects of ethyl acetate extract on a) MCF-7, b) SKMEL-3 and c) K562 cells after 24, 48 and 72 h of tretment. 
Cells were treated with different concentrations of extract (0.001-0.25 mg/mL).Values are presented as mean ± SE of three independent 
experiments.
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Flowcytometry analysis 
Cell cycle phase distribution was determined 
by analytical DNA flowcytometry. MCF-7 
cells were incubated for 72 h with 0.001 mg/
mL (1/2 IC50) of ethyl acetate fraction. Cells 
were harvested and adjusted to 106 cells/plate 
in 6-well plates and stained with Propidium 
Iodide (PI) reagent at 37 ºC for 15 min in the 
dark. PARTEC flowcytometer (Partec GmbH, 
Munster, Germany) with Flowjo software was 
used to analyze DNA content using UV light. 
The percentage of cells in the various phases 
was determined, and statistical analysis of data 
from flowcytometry experiments was carried 
out.
Identification of apoptosis by annexin-V/PI 
staining 
Following treatment, 106 cells were washed 
in PBS and resuspended in 100 µL of annexin-
V-FLUOS labeling solution containing 2 
µL annexin-V-FLUOS labeling agent, 2 µL 
Propidium Iodide (PI) solution and 1 mL 
incubation buffer to achieve a concentration 
of 106 cells/mL. Following incubation at 
37 ºC for 15 minutes, cells were analyzed 
by flowcytometry. Annexin-V binds to cells 
expressing phosphatidylserine on the outer 
layer of the cell membrane, and PI stains the 
cellular DNA of those with a compromised cell 
membrane. This allows for the discrimination 
of live cells (unstained with either fluorochrome 
or PI) from apoptotic (stained with annexin-V) 
and necrotic cells (stained with PI).
Western blot analysis 
MCF-7 cells were treated with ethyl acetate 
fraction at 1/2 IC50 concentration for 72 h. 
Proteins were extracted from distinctively 
treated cells, collected and lysed in lysis buffer 
(Tris 62.5 mM (pH 6.8), DTT 50 mM, SDS 10%, 
glycerol) in the presence of protease inhibitors. 
Then, equal amounts of protein were heated to 
95 ºC, separated in 12% SDS- polyacrylamide 
gels and transferred to PVDF membranes. The 
membrane was then blocked for 2 h in TBST 
(50 mmol/L Tris-HCl, pH 7.6, 150 mmol/L 
NaCl and 0.1% Tween 20) containing 1% 
(w/v) casein, and then incubated with primary 
antibodies overnight, followed by incubation 
with HRP conjugated goat anti-rabbit IgG for 
2 h. Blots were then developed using ECL 
advance western blotting detection kit. The 
signals from each protein band were normalized 
against the GAPDH (Glyceraldehyde Phosphate 
Dehydrogenase) content using the polyclonal 
anti-GAPDH antibody. The expression level of 
control was designated value “1”, and thereby 
the expression ratios of the treatments were 
expressed in relation to the control.
Statistical analysis 
IC50 values were calculated by non-linear 
regression analysis with Graph Pad Prism 6.0. 
Results were expressed as the mean ± SE of at 
least triplicate determinations, and statistical 
comparisons were based on ANOVA followed 
by the Tukey’s post test. P < 0.05 was considered 
to be significant.
Results and Discussion
It has been shown that German chamomile 
extracts caused minimal growth inhibitory 
responses in normal cells, whereas a significant 
decrease in cell viability was observed in 
various human cancer cell lines. In this regard, 
German chamomile contains polyphenols such 
Table 1. IC50 values (mg of extract/mL) for antiproliferative 
activity of Chamaemelum nobile ethyl acetate extracts towards 
MCF-7, K562 and SKMEL3 cells a.
Cells Time Ethyl acetate fraction
MCF-7
24 h 0.09(0.07-0.1)
48h 0.09(0.07-0.1)
72h 0.002(0.002-0.004)
K562
24 h 0.06(0.05-0.07)
48h 0.04(0.03-0.04)
72h 0.04(0.03-0.04)
SKMEL-3
24 h 0.15 (0.14-0.17)
48h 0.1(0.09-0.11)
72h 0.04(0.04-0.05)
aMCF-7: Human breast adenocarcinoma, K562 : Human 
erythroleukemia, SKMEL-3: Human melanoma cell  lines. 
Data are expressed as mean of three separate experiments run 
in triplicate and 95% confidence intervals.
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as apigenin possessing high anticancer activity 
(16). Furthermore, chamomile exposure resulted 
in differential apoptosis in cancer cells but not 
in normal cells at similar concentrations (17). 
We have recently evaluated the antiproliferative 
activity of different fractions obtained from 
C. nobile (Roman chamomile)  in human oral 
cancer cells (BHY) (data not shown). Our results 
indicated that chloroform as well as ethyl acetate 
fractions both had considerable and similar IC50 
values, particularly after 72h of incubation (0.05 
vs. 0.09 mg/mL).  Additionally, previous studies 
provide evidence that polar chemicals including 
phenolic compounds found in chamomile species 
can exert health beneficial effects including 
tumor-suppressive property (16, 18). Considering 
this supposition and that the ethyl acetate fraction 
contains polar bioactive compounds, we decided 
to evaluate the antiproliferative effects of ethyl 
acetate fraction obtained from aerial parts of 
C. nobile.  For this purpose, we examined the 
effect of different concentrations of ethyl acetate 
fraction on MCF-7, K562 and SKMEL-3 cells 
cytotoxicity using the MTT assay at 24, 48 and 
72 h.  Ethyl acetate extract exhibited remarkable 
growth inhibitory activity as illustrated by the 
concentration-dependent curves in Figure 1 at 
different times. The IC50 results are summarized 
in Table 1. Considering all IC50 values, the best 
cytotoxic effect obtained after 72 h treatment 
of MCF-7 cells. Additionally, the IC50 value 
for the ethyl acetate fraction obtained after 72 
h treatment of human gingival fibroblast cells 
(HGF) as normal cell line (IC50 = 0.05 mg/mL). 
As the results shown, the IC50 value in normal 
cell line was higher than that of cancer cell lines 
showing selectivity between cancerous and non-
cancerous cells. In this regard, the selectivity 
index in MCF-7 is much higher than in SKMEL-3 
or K562 cells. Our results are in close agreement 
with Guimaraes et al. who studied the cytotoxic 
effect of decoction, infusion and extract of C. 
nobile on the growth of human tumour cells 
(19). From these results, it is worth mentioning 
SKMEL-3 48h 0.1(0.09-0.11) 
 72h 0.04(0.04-0.05) 
aMCF-7: Human breast adenocarcinoma, K562 : Human erythroleukemia, SK-MEL-3: Human melanoma 
cell  lines. Data are expressed as mean of three separate experiments run in triplicate and 95% confidence 
intervals. 
 
 
Next, we confirmed the antiproliferative effect of ethyl acetate fraction on breast 
cancer cells. As shown in Table 2, exposure to 0.001 mg/mL of ethyl acetate fraction slightly 
inhibited cell division of PI- stained MCF-7 cells after 72 h. Cell cycle analysis of MCF-7 
cells-treated with ½ IC50 concentration of the ethyl acetate fraction, exhibited an 
inconsiderable increase in sub-G1 population from 4.27% to 5.8% after 72 h treatment. 
Concomitantly, the percentage of cells in the G2 phase also increased marginally from 28.6 ± 
2.5% in control cells to 32.7±4.4% in the ½ IC50 treated group suggesting a slight G2/M 
phase arrest (Table 2).In order to explore whether ethyl acetate fraction showed cytotoxicity 
to MCF-7 cells through inducing apoptosis, the cells were stained with annexin-V/PI and 
analyzed by flowcytometry. In this assay, detection of the externalization of 
phosphatidylserine was performed. Based on Table 3, there is a pattern of cell population 
shifting from viable to late apoptosis/necrosis in MCF-7 cells. The percentage of late 
apoptotic cells in MCF-7 increased gradually from 3.7% in solvent control group up until 
8.6% in ½ IC50 of the treatment group. A similar pattern can be seen in the necrotic cells as 
well, according to Figure 2. The results obtained from annexin-V/PI assay indicated that ethyl 
acetate fraction showed antitumor activities through inducing mainly late apoptotic and 
necrotic cell death. 
 
Figure 2. Flowcytometric analysis of annexin-V/PI to quantify extract-induced apoptosis in 
MCF-7 cells. a) Dot plot of MCF-7 cells as control. b) Dot plot of MCF-7 cells treated with 
DMSO for 72 h. c) Dot plot of MCF-7 cells treated with 1/2 IC50 concentration of ethyl 
acetate fraction for 72 h. 
Figure 2. Flowcytometric analysis of annexin-V/PI to quantify extract-induced apoptosis in MCF-7 cells. a) Dot plot of MCF-7 cells as 
control. b) Dot plot of MCF-7 cells treated with DMSO for 72 h. c) Dot plot of MCF-7 cells treated with 1/2 IC50 concentration of ethyl 
acetate fraction for 72 h.
Treatment
  MCF-7
Sub-G1
(mean ± SE)
G0/G1
(mean ± SE)
S
(mean ± SE)
G2/M
(mean ± SE)
Control 4.27 ± 1.2 31.3 ± 3.3 23.9 ± 0.75 28.56 ± 2.5
Ethyl acetate fraction 
(1/2 IC50)
5.8 ± 1.9 31.39 ± 1.4 22.53 ± 0.28 32.7 ± 4.4
aAt the indicated cell, distribution of the cells in sub-G1, Go/G1, S and G2/M phase was analyzed by flowcytometry. Results are expressed 
as total cells. Data represent means of triplicate experiment.
Table 2. Effect of ethyl acetate fraction on cell cycle progression with respect to controla.
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that the anticancer compounds extracted from C. 
nobile are concentrated in ethyl acetate fraction
Next, we confirmed the antiproliferative 
effect of ethyl acetate fraction on breast 
cancer cells. As shown in Table 2, exposure to 
0.001 mg/mL of ethyl acetate fraction slightly 
inhibited cell division of PI- stained MCF-7 cells 
after 72 h. Cell cycle analysis of MCF-7 cells 
treated  with ½ IC50 concentration of the ethyl 
acetate fraction, exhibited an inconsiderable 
increase in sub-G1 population from 4.27% to 
5.8% after 72h of treatment. Concomitantly, 
the percentage of cells in the G2 phase also 
increased marginally from 28.6 ± 2.5% in control 
cells to 32.7±4.4% in the ½ IC50 treated group 
suggesting a slight G2/M phase arrest (Table 2). 
In order to explore whether ethyl acetate fraction 
showed cytotoxicity to MCF-7 cells through 
inducing apoptosis, the cells were stained with 
annexin-V/PI and analyzed by flowcytometry. 
In this assay, detection of the externalization 
of phosphatidylserine was performed. Based 
on Table 3, there is a pattern of cell population 
shifting from viable to late apoptosis/necrosis in 
MCF-7 cells. The percentage of late apoptotic 
cells in MCF-7 increased gradually from 3.7% 
in solvent control group up until 8.6% in ½ IC50 
of the treatment group. A similar pattern can be 
seen in the necrotic cells as well, according to 
Figure 2. The results obtained from annexin-V/
PI assay indicated that ethyl acetate fraction 
showed antitumor activities through inducing 
mainly late apoptotic and necrotic cell death.
It has been reported that anticancer effects 
of major phenolic compounds extracted from 
Matricaria chamomile (German chamomile) 
Table 3.  Percentage of breast adenocarcinoma cells in each state after treatment with ethyl acetate fraction at 0.001 mg/mL for 72 h of 
incubation.
Compound Vital cells (%) An–/PI–
Early apoptosis (%) 
An+/PI–
Late apoptosis (%) 
An+/PI+
Necrosis (%)
An–/PI+
Ethyl acetate 
fraction (1/2 IC50)
73.5 ±  4.9 1.4 ± 0.2 8.6 ± 2.7  14.3 ±  0.92
Control 83.5 ± 1.6 2.2 ± 0.3 3.7 ± 0.1 6.2 ± 0.84
Figure 3. Expression analysis of apoptosis associated proteins by Western blot analysis. MCF-7 cells were treated by ethyl acetate 
fraction at ½ IC50 concentration a) Immunoblot showing the expression levels of Bax, Bcl-2 and GADPH. Statistical analysis of b) Bax, c) 
Bcl-2 expression and d) Ratios of Bax/Bcl-2 compared with control after 72h of treatment. The results of three independent experiments 
are presented as mean ± standard error. * p<0.05 and ** p<0.01 indicate significant differences of each group with the control group.
a)
c) d)b)
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in different cancer cells were based on the 
activation of the classical apoptosis response, 
particularly the mitochondrial pathway of the 
apoptosis (16, 20). These studies prompted us to 
elucidate the mechanism of cytotoxic effects of 
ethyl acetate fraction. To evaluate the potential 
mediators of ethyl acetate fraction-induced 
cell damage, we analyzed Bax/Bcl-2 proteins 
ratio as cell apoptosis markers. The cells were 
exposed to 0.001 mg/mL of the extract (1/2 IC50 
concentration) for 72 h. As indicated in Figure 3, 
Bax protein was remarkably increased in ethyl 
acetate-treated cells, while the Bcl-2 protein 
significantly (𝑃 < 0.05) decreased. However, it 
is important to mention that the Bcl-2 is highly 
expressed in MCF-7 cells. Consequently, there 
was a statistically significant increase (𝑃 < 
0.01) in the Bax / Bcl-2 protein ratio in the cells 
exposed to 0.001 mg/mL of the extract (Figure 
3). This increase is important because it has been 
recently proposed that the ratio of Bax to Bcl-2 
may govern the sensitivity of cells to apoptotic 
stimuli from anticancer agents (21). These data 
also supported our annexin –V and cell cycle 
analysis results suggesting apoptosis induction 
by treatment of C. nobile ethyl acetate fraction in 
MCF-7 cells through the blockade of cell cycle 
progression. These results are in line with data 
reported by Srivastava et al. who demonstrated 
a notable apoptotic effect of methanolic extract 
in cancer cell lines which was due to flavonid 
compounds, specially apigenin derivatives (16).
This study proposes C. nobile ethyl acetate 
fraction as a promising anti-cancer agent 
especially in treating breast cancer. Ethyl acetate 
fraction induced apoptosis in MCF-7 cells by 
activating the mitochondrial death pathway via the 
involvement of G2/M phase arrest. However, we 
do not know whether apoptosis induced by ethyl 
acetate fraction relies on a single or combined 
effects of different compounds detected in this 
extract. Finally, C. nobile ethyl acetate extract 
deserves further investigation to fully explain the 
mechanism of apoptosis inducing effect and the 
chemical constituents involved in this activity.
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